Header

UZH-Logo

Maintenance Infos

Browse by Creators

Navigate back| Up a level
Export as
Number of items: 38.

Latus, J; Kitterer, D; Segerer, S; Artunc, F; Alscher, M D; Braun, N (2015). Severe thrombocytopenia in hantavirus-induced nephropathia epidemica. Infection, 43(1):83-87.

Thalhammer, C; Segerer, S (2014). Zugänge für die Hämodialyse. Deutsche Medizinische Wochenschrift, 139(31-32):1562-1564.

Berthier, C C; Bethunaickan, R; Gonzalez-Rivera, T; Nair, V; Ramanujam, M; Zhang, W; Bottinger, E P; Segerer, S; Lindenmeyer, M; Cohen, C D; Davidson, A; Kretzler, M (2012). Cross-species transcriptional network analysis defines shared inflammatory responses in murine and human lupus nephritis. Journal of Immunology, 15(189):988-1001.

Braun, N; Fritz, P; Ulmer, C; Latus, J; Kimmel, M; Biegger, D; Ott, G; Reimold, F; Thon, K P; Dippon, J; Segerer, S; Alscher, M D (2012). Histological criteria for encapsulating peritoneal sclerosis - a standardized approach. PLoS ONE, 7(11):e48647.

Kocher, C; Segerer, S; Schleich, A; Caduff, R; Wyler, L G; Müller, V; Beck, B; Blum, J; Kamarachev, J; Mueller, N J (2012). Skin lesions, malaise, and heart failure in a renal transplant recipient. Transplant Infectious Disease, 14(4):391-397.

Seeger, H; Bonani, M; Segerer, S (2012). The role of lymphatics in renal inflammation. Nephrology, Dialysis, Transplantation, 27(7):2634-2641.

Segerer, S (2011). Response to Comment on: Lin et al. (2010) Immune Cell–Derived C3 Is Required for Autoimmune Diabetes Induced by Multiple Low Doses of Streptozotocin. Diabetes;59:2247–2252. Diabetes, 59:2247-2248.

Schwegler, I; Segerer, S (2011). A painful fistula. Circulation, 123(22):2606.

Raina, S; Honer, M; Krämer, S D; Liu, Y; Wang, X; Segerer, S; Wüthrich, R P; Serra, A L (2011). Anti-VEGF antibody treatment accelerates polycystic kidney disease. American Journal of Physiology. Renal Physiology, 301(4):F773-F783.

Lindenmeyer, M; Noessner, E; Nelson, P J; Segerer, S (2011). Dendritic cells in experimental renal inflammation - Part I. Nephron Experimental Nephrology, 119(4):e83-e90.

Noessner, E; Lindenmeyer, M; Nelson, P J; Segerer, S (2011). Dendritic cells in human renal inflammation - Part II. Nephron Experimental Nephrology, 119(4):e91-e98.

Welsh-Bacic, D; Lindenmeyer, M; Cohen, C D; Draganovici, D; Mandelbaum, J; Edenhofer, I; Ziegler, U; Regele, H; Wüthrich, R P; Segerer, S (2011). Expression of the chemokine receptor CCR6 in human renal inflammation. Nephrology, Dialysis, Transplantation, 26(4):1211-1220.

Figel, A M; Brech, D; Prinz, P U; Lettenmeyer, U K; Eckl, J; Turqueti-Neves, A; Mysliwietz, J; Anz, D; Rieth, N; Muenchmeier, N; Buchner, A; Porubsky, S; Siegert, S I; Segerer, S; Nelson, P J; Noessner, E (2011). Human renal cell carcinoma induces a dendritic cell subset that uses T-cell crosstalk for tumor-permissive milieu alterations. American Journal of Pathology, 179(1):436-451.

Neusser, M A; Lindenmeyer, M T; Edenhofer, I; Gaiser, S; Kretzler, M; Regele, H; Segerer, S; Cohen, C D (2011). Intrarenal production of B cell survival factors in human lupus nephritis. Modern Pathology, 24(1):98-107.

Schleich, A; Gerber, L; Wüthrich, R P; Segerer, S (2011). Peri-renal hematoma after intraperitoneal cefazolin treatment for peritonitis. Peritoneal Dialysis International, 31(4):505-507.

Sen, K; Lindenmeyer, M T; Gaspert, A; Eichinger, F; Neusser, M A; Kretzler, M; Segerer, S; Cohen, C D (2011). Periostin is induced in glomerular injury and expressed de novo in interstitial renal fibrosis. American Journal of Pathology, 179(4):1756-1767.

Braun, N; Alscher, D M; Fritz, P; Edenhofer, I; Kimmel, M; Gaspert, A; Reimold, F; Bode-Lesniewska, B; Ziegler, U; Biegger, D; Wüthrich, R P; Segerer, S (2011). Podoplanin-positive cells are a hallmark of encapsulating peritoneal sclerosis. Nephrology, Dialysis, Transplantation, 26(3):1033-1041.

Lin, M; Yin, N; Murphy, B; Medof, M E; Segerer, S; Heeger, P S; Schröppel, B (2010). Immune cell-derived c3 is required for autoimmune diabetes induced by multiple low doses of streptozotocin. Diabetes, 59(9):2247-2252.

Hoffmann, U; Bergler, T; Segerer, S; Rümmele, P; Krüger, B; Banas, M C; Reinhold, S; Banas, B; Krämer, B K (2010). Impact of chemokine receptor CX3CR1 in human renal allograft rejection. Transplant Immunology, 23(4):204-208.

Segerer, S (2010). The Role of Chemokine Receptors in Acute Lung Allograft Rejection. European Respiratory Journal:167-175.

Sostak, C; Padovan, C S; Eigenbrod, S; Roeber, S; Segerer, S; Schankin, C; Siegert, S; Saam, T; Theil, D; Kolb, H J; Kretzschmar, H; Straube, A (2010). Cerebral angiitis in four patients with chronic GVHD. Bone Marrow Transplantation, 45(7):1181-1188.

Gross, O; Girgert, R; Beirowski, B; Kretzler, M; Kang, H G; Kruegel, J; Miosge, N; Busse, A C; Segerer, S; Vogel, W F; Müller, G A; Weber, M (2010). Loss of collagen-receptor DDR1 delays renal fibrosis in hereditary type IV collagen disease. Matrix Biology, 29(5):346-56.

Neusser, M A; Kraus, A K; Regele, H; Cohen, C D; Fehr, T; Kerjaschki, D; Wüthrich, R P; Penfold, M E; Schall, T; Segerer, S (2010). The chemokine receptor CXCR7 is expressed on lymphatic endothelial cells during renal allograft rejection. Kidney International, 77(9):801-808.

Bergamin, B; Senn, O; Corsenca, A; Dutkowski, P; Weber, M; Wüthrich, R P; Segerer, S; Pechula Thut, M (2010). Finding the right position: a three-year, single-center experience with the self-locating catheter. Peritoneal Dialysis International, 30(5):519-523.

Neusser, M A; Lindenmeyer, M T; Moll, A G; Segerer, S; Edenhofer, I; Sen, K; Stiehl, D P; Kretzler, M; Gröne, H J; Schlöndorff, D; Cohen, C D (2010). Human nephrosclerosis triggers a hypoxia-related glomerulopathy. American Journal of Pathology, 176(2):594-607.

Segerer, S; Jedlicka, J; Wüthrich, R P (2010). Atypical chemokine receptors in renal inflammation. Nephron Experimental Nephrology, 115(4):e89-e95.

Jedlicka, J; Soleiman, A; Draganovici, D; Mandelbaum, J; Ziegler, U; Regele, H; Wüthrich, R P; Gross, O; Anders, H J; Segerer, S (2010). Interstitial inflammation in Alport syndrome. Human Pathology, 41(4):582-593.

Tian, Y; Chen, J; Gaspert, A; Segerer, S; Clavien, P A; Wüthrich, R P; Fehr, T (2010). Kidney transplantation in mice using left and right kidney grafts. Journal of Surgical Research, 163(2):e91-e97.

Starke, A; Lindenmeyer, M T; Segerer, S; Neusser, M A; Rüsi, B; Schmid, D M; Cohen, C D; Wüthrich, R P; Fehr, T; Waeckerle-Men, Y (2010). Renal tubular PD-L1 (CD274) suppresses alloreactive human T-cell responses. Kidney International, 78(1):38-47.

Sayyed, S G; Hägele, H; Kulkarni, O P; Endlich, K; Segerer, S; Eulberg, D; Klussmann, S; Anders, H J (2009). Podocytes produce homeostatic chemokine stromal cell-derived factor-1/CXCL12, which contributes to glomerulosclerosis, podocyte loss and albuminuria in a mouse model of type 2 diabetes. Diabetologia, 52(11):2445-2454.

Lech, M; Avila-Ferrufino, A; Allam, R; Segerer, S; Khandoga, A; Krombach, F; Garlanda, C; Mantovani, A (2009). Resident dendritic cells prevent postischemic acute renal failure by help of single Ig IL-1 receptor-related protein. Journal of Immunology, 183(6):4109-4118.

Segerer, S; Johnson, Z; Rek, A; Baltus, T; von Hundelshausene, P; Kungl, A J; Proudfoot, A E I; Weber, C; Nelson, P J (2009). The basic residue cluster 55KKWVR59 in CCL5 is required for in vivo biologic function. Molecular Immunology, 46(13):2533-2538.

Wüthrich, R P; Segerer, S (2009). Renale Salzregulation: Physiologische Mechanismen und ihre medikamentöse Beeinflussung. Cardiovasc, 5:6-10.

Lichtnekert, J; Vielhauer, V; Zecher, D; Kulkarni, O P; Clauss, S; Segerer, S; Hornung, V; Mayadas, T N; Beutler, B; Akira, S; Anders, H J (2009). Trif is not required for immune complex glomerulonephritis: dying cells activate mesangial cells via Tlr2/Myd88 rather than Tlr3/Trif. American Journal of Physiology: Renal Physiology, 296(4):F867-F874.

Vielhauer, V; Allam, R; Lindenmeyer, M T; Cohen, C D; Draganovici, D; Mandelbaum, J; Eltrich, N; Nelson, P J; Anders, H J; Pruenster, M; Rot, A; Schlöndorff, D; Segerer, S (2009). Efficient renal recruitment of macrophages and T cells in mice lacking the duffy antigen/receptor for chemokines. American Journal of Pathology:119-131.

Gross, O; Borza, D B; Andres, H J; Licht, C; Weber, M; Segerer, S; Torra, R; Gubler, M C; Heidet, L; Harvey, S; Cosgrove, D; Lees, G; Kashtan, C; Gregory, M; Savige, J; Ding, J; Thorner, P; Abrahamson, D R; Antignac, C; Tryggvason, K; Hudson, B; Miner, J H (2009). Stem cell therapy for Alport syndrome: the hope beyond the hype. Nephrology, Dialysis, Transplantation, 24(3):731-734.

Pruenster, M; Mudde, L; Bombosi, P; Dimitrova, S; Zsak, M; Middleton, J; Richmond, A; Graham, G; Segerer, S; Nibbs, R; Rot, A (2009). The Duffy antigen receptor for chemokines transports chemokines and supports their promigratory activity. Nature Immunology, 10(1):101-108.

Lehmann, I; Fischereder, M; Böhmig, G A; Regele, H; Exner, M; Raith, M; Weiss, N; Segerer, S (2008). The source matters: no impact of the CCL2/MCP-1-1-2518G polymorphism of the donor on renal allograft outcome during the first year after transplantation. Transplant Proceedings, 40(10):3359-3361.

This list was generated on Mon May 21 05:34:38 2018 CEST.